FREE SHIPPING on all orders to continental US!

Boiron

Boiron ColdCalm On the Go 160

Boiron

Boiron ColdCalm On the Go 160

Barcode: 306969098424
Size: 160
Form: Pellet

ColdCalm On the Go 160 Pellet

Description

Find relief wherever you go with ColdCalm On the Go by Boiron. This non-drowsy cold medicine is made with pure active ingredients that target symptoms at every stage of the cold. The meltaway pellets dissolve in your mouth without water, allowing you to act fast to relieve sneezing, runny nose, nasal congestion, and minor sore throat pain.* Recommended for ages 3 and up, ColdCalm On the Go Pellets are offered in convenient, portable tubes for relief that travels with you.

Active Ingredients

Allium cepa 3C HPUS, Apis mellifica 6C HPUS, Belladonna 6C HPUS, Eupatorium perfoliatum 3C HPUS, Gelsemium sempervirens 6C HPUS, Kali bichromicum 6C HPUS, Nux vomica 3C HPUS, Phytolacca decandra 6C HPUS, Pulsatilla 6C HPUS

  • Meltaway pellets dissolve in your mouth to relieve symptoms at every stage of the cold
  • Compact and portable tubes for home, work, or travel.
  • Non-drowsy, non-habit forming.
  • No risk of a rebound effect or interaction with other medications or supplements.
  • Recommended for adults and children ages 3 and up.
  • No artificial sweeteners, flavors, colors, or preservatives.
  • Boirons cold relief line also includes ColdCalm Meltaway Tablets, ColdCalm Liquid Doses for kids and babies, and Chestal cough syrup.
  • Also try Oscillococcinum for flu symptoms and Chestal Cough & Mucus Pellets.

Suggested Use As a dietary supplement Adults and children 3 years of age and older At the onset of symptoms, dissolve 5 pellets under the tongue every 15 minutes for 1 hour. Then take 5 pellets every 6 hours. Decrease frequency with improvement. Children under 3 years of age Ask a doctor. - Or as directed by your healthcare professional.

WarningsKeep out of reach of children. As with all dietary supplements, consult your healthcare professional before use. See product label for more information.


Subscribe